Ads
related to: schizophrenia symptoms- Real Patient Stories
Watch the Treatment Journeys of
Real Adult Patients
- Patient Support Resources
Find Access, Affordability and
Treatment Support for Your Patients
- Short-Term Study Results
Find the Results of a Short-Term
Schizophrenia Study
- Dosing Info
Get Dosing & Information for
This Long-Acting Treatment Option
- Instruction to Administer
Download Instructions for Use
to Administer this LAI
- Efficacy
Learn About the Efficacy & Safety
of This LAI Treatment
- Real Patient Stories
Search results
‘I haven’t even buried my son’: Family of Anthony Johnson demands answers in jail death
Fort Worth Star-Telegram via Yahoo News· 7 days agoAnthony Johnson’s family demanded answers and the release of videos showing what happened to him in...
Fact Check: Is Marijuana Legalization Hurting Teen Mental Health?
Benzinga· 4 hours agoIf you read this January 10 Wall Street Journal piece, you might conclude that a wave of...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 5 days agoNeurocrine stock jumped nearly 5% on April 24, the day after the company unveiled the midstage test...
Why Is Teva Pharmaceutical Stock Trading Higher On Wednesday? - Teva Pharmaceutical Indus...
Benzinga· 6 days agoWednesday, Teva Pharmaceutical Industries Ltd TEVA and Medincell announced results from the efficacy...
First Results of Magnetic Seizure Therapy for Bipolar Mania
Medscape· 7 days agoMagnetic seizure therapy (MST) offers similar efficacy as electroconvulsive therapy (ECT) in...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript May 7, 2024...
Minerva Neurosciences (NASDAQ:NERV) Downgraded to Sell at StockNews.com
ETF DAILY NEWS· 5 days agoMinerva Neurosciences (NASDAQ:NERV – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Friday. Separately, HC Wainwright ...
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
Zacks via Yahoo Finance· 5 days agoPipeline Updates In March 2024, Acadia announced the failure of its late-stage study evaluating...
Opinion | Doctors, Not Judges, Should Decide When to Treat Patients Without Their Consent
New York Times· 1 day agoDr. Jauhar is a cardiologist in New York who writes frequently about medical care and public health....
Raymond James Cuts HLS Therapeutics (TSE:HLS) Price Target to C$4.00
ETF DAILY NEWS· 2 days agoHLS Therapeutics (TSE:HLS – Free Report) had its target price cut by Raymond James from C$5.00 to C$4.00 in a report issued on Friday morning, BayStreet.CA reports. A number of other research ...